Cargando…

Editorial: Combating Diabetes and Diabetic Kidney Disease

Detalles Bibliográficos
Autores principales:	Srivastava, Swayam Prakash, Kanasaki, Keizo, Goodwin, Julie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295890/ https://www.ncbi.nlm.nih.gov/pubmed/34305620 http://dx.doi.org/10.3389/fphar.2021.716029

Ejemplares similares

Editorial: Receptor Biology and Cell Signaling in Diabetes
por: Srivastava, Swayam Prakash, et al.
Publicado: (2022)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney
por: Srivastava, Swayam Prakash, et al.
Publicado: (2019)

Loss of Mitochondrial Control Impacts Renal Health
por: Srivastava, Swayam Prakash, et al.
Publicado: (2020)

Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms
por: Bhatia, Divya, et al.
Publicado: (2023)

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
por: Srivastava, Swayam Prakash, et al.
Publicado: (2013)

Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis
por: Srivastava, Swayam Prakash, et al.
Publicado: (2018)

N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
por: Kanasaki, Keizo, et al.
Publicado: (2014)

Lipid mediators in diabetic nephropathy
por: Srivastava, Swayam Prakash, et al.
Publicado: (2014)

Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs
por: Srivastava, Swayam Prakash, et al.
Publicado: (2020)

Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition
por: Nagai, Takako, et al.
Publicado: (2014)

Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen
por: Nitta, Kyoko, et al.
Publicado: (2016)

Cancer Biology and Prevention in Diabetes
por: Srivastava, Swayam Prakash, et al.
Publicado: (2020)

Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis
por: Srivastava, Swayam Prakash, et al.
Publicado: (2016)

Combating Kidney Fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2014)

Combat Diabetic Nephropathy: From Pathogenesis to Treatment
por: Gohda, Tomohito, et al.
Publicado: (2014)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
por: Shi, Sen, et al.
Publicado: (2016)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2013)

Editorial: Advances in antimicrobial therapy and combating resistance
por: Ghazi, Islam M., et al.
Publicado: (2023)

Classical molecule in diabetic kidney hypertrophy is linked to defects in self‐eating through fine‐tuning
por: Takagaki, Yuta, et al.
Publicado: (2021)

N‐acetyl‐seryl‐aspartyl‐lysyl‐proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects
por: Kanasaki, Keizo
Publicado: (2020)

Drugs for Diabetes: From Pharmacology to Clinical Application
por: Srivastava, Swayam Prakash
Publicado: (2023)

Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon
por: Kanasaki, Keizo, et al.
Publicado: (2019)

Loss of endothelial glucocorticoid receptor accelerates organ fibrosis in db/db mice
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Loss of endothelial glucocorticoid receptor accelerates organ fibrosis in db/db mice
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
por: Pak, Eun Seon, et al.
Publicado: (2022)

Editorial: Combating Redox Imbalance-Associated Complications With Natural Products
por: Pandey, Abhay K., et al.
Publicado: (2021)

Editorial: New drugs, approaches, and strategies to combat antimicrobial resistance
por: Singh, Chandra Kant, et al.
Publicado: (2023)

The Relevance of the Renin-Angiotensin System in the Development of Drugs to Combat Preeclampsia
por: Ueki, Norikazu, et al.
Publicado: (2015)

Editorial: Ion channels and transporters in diabetes and metabolic diseases
por: Puljung, Michael, et al.
Publicado: (2022)

Editorial: Combating cancer with natural products: Non-coding RNA and RNA modification
por: Huang, Yongye, et al.
Publicado: (2023)

Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study
por: Makino, Hirofumi, et al.
Publicado: (2023)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021)

Editorial: Pathogenesis of diabetic foot ulcers
por: Peng, Zhihong, et al.
Publicado: (2023)

FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway
por: Li, Jinpeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_348n0rt2l8c2258j4a4sl457p5